Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	FoxO signaling pathway	4/131	1.286407583499158e-05	0.0005636649160036656	41.68503937007874	-108.26148696115065	EGFR;KRAS;PRKAA2;STK11
KEGG_2021_Human	Bladder cancer	3/41	1.4210039899252074e-05	0.0005636649160036656	90.56390977443608	-146.56914663391532	EGFR;KRAS;TP53
KEGG_2021_Human	Longevity regulating pathway	4/102	4.7476288106462685e-06	0.0005636649160036656	54.21768707482993	-134.5540755438832	KRAS;PRKAA2;STK11;TP53
KEGG_2021_Human	PI3K-Akt signaling pathway	5/354	3.3006559621061475e-05	0.0009681457659991953	22.117478510028654	-72.75889105971214	EGFR;KRAS;PRKAA2;STK11;TP53
KEGG_2021_Human	Endometrial cancer	3/58	4.0678393529377954e-05	0.0009681457659991953	62.43896103896104	-110.94009813873689	EGFR;KRAS;TP53
KEGG_2021_Human	Central carbon metabolism in cancer	3/70	7.160249860764975e-05	0.0010899948275426342	51.17910447761194	-94.92366080084827	EGFR;KRAS;TP53
KEGG_2021_Human	Glioma	3/75	8.803803111601103e-05	0.0010899948275426342	47.595238095238095	-89.5568748406007	EGFR;KRAS;TP53
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.0010899948275426342	46.93737769080235	-88.55605413655218	EGFR;KRAS;TP53
KEGG_2021_Human	Melanoma	3/72	7.791014338658423e-05	0.0010899948275426342	49.683229813664596	-92.7008152698569	EGFR;KRAS;TP53
KEGG_2021_Human	Non-small cell lung cancer	3/72	7.791014338658423e-05	0.0010899948275426342	49.683229813664596	-92.7008152698569	EGFR;KRAS;TP53
KEGG_2021_Human	Thermogenesis	4/232	0.00012150057084905025	0.001313701339922578	22.923976608187136	-63.412309433922275	COX8A;KRAS;PRKAA2;SDHB
KEGG_2021_Human	Colorectal cancer	3/86	0.0001324740846980751	0.001313701339922578	41.230636833046475	-79.65388581050792	EGFR;KRAS;TP53
KEGG_2021_Human	Prostate cancer	3/97	0.00018948670381727933	0.0017345321349427876	36.35562310030395	-71.7056117119453	EGFR;KRAS;TP53
KEGG_2021_Human	Autophagy	3/137	0.0005248515914701949	0.004461238527496657	25.375266524520256	-52.38188378130509	KRAS;PRKAA2;STK11
KEGG_2021_Human	Oxytocin signaling pathway	3/154	0.0007390260491982426	0.004651815390870572	22.47019867549669	-46.86692877135684	EGFR;KRAS;PRKAA2
KEGG_2021_Human	Hepatitis C	3/157	0.0007818177127513567	0.004651815390870572	22.024118738404454	-46.00245527612638	EGFR;KRAS;TP53
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.004651815390870572	22.31954887218045	-46.57552582678881	COX8A;PRKAA2;SDHB
KEGG_2021_Human	Breast cancer	3/147	0.0006451123837261741	0.004651815390870572	23.583333333333332	-49.00315377085699	EGFR;KRAS;TP53
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.004651815390870572	23.25440313111546	-48.37496566440217	EGFR;KRAS;TP53
KEGG_2021_Human	mTOR signaling pathway	3/154	0.0007390260491982426	0.004651815390870572	22.47019867549669	-46.86692877135684	KRAS;PRKAA2;STK11
KEGG_2021_Human	Thyroid cancer	2/37	0.0008976760152685225	0.0050868307531882935	57.378571428571426	-64.24352876962546	KRAS;TP53
KEGG_2021_Human	Hepatocellular carcinoma	3/168	0.0009522461559574535	0.005150786025406225	20.527272727272727	-43.06507884394289	EGFR;KRAS;TP53
KEGG_2021_Human	Proteoglycans in cancer	3/205	0.0016941022902244062	0.00876513793637845	16.68882602545969	-35.25303962280841	EGFR;KRAS;TP53
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.010975293014597107	15.146718146718147	-31.989452913184095	EGFR;KRAS;TP53
KEGG_2021_Human	Adipocytokine signaling pathway	2/69	0.0030959091544989293	0.013644932940198985	29.854477611940297	-38.032897794694755	PRKAA2;STK11
KEGG_2021_Human	Parkinson disease	3/249	0.0029568377027043165	0.013644932940198985	13.627177700348431	-28.69609856443984	COX8A;SDHB;TP53
KEGG_2021_Human	Mitophagy	2/68	0.0030081604419031007	0.013644932940198985	30.310606060606062	-38.524679686703344	KRAS;TP53
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.01591052081051178	27.006756756756758	-34.90410589940028	KRAS;TP53
KEGG_2021_Human	ErbB signaling pathway	2/85	0.004661598778005346	0.01877615784797801	24.051204819277107	-31.541623523071053	EGFR;KRAS
KEGG_2021_Human	MAPK signaling pathway	3/294	0.0047334851717591615	0.01877615784797801	11.45360824742268	-23.841254126382374	EGFR;KRAS;TP53
KEGG_2021_Human	GnRH signaling pathway	2/93	0.005556617161068888	0.018892498347634217	21.914835164835164	-29.03004575134454	EGFR;KRAS
KEGG_2021_Human	Gap junction	2/88	0.0049885835861889025	0.018892498347634217	23.203488372093023	-30.553595052356073	EGFR;KRAS
KEGG_2021_Human	MicroRNAs in cancer	3/310	0.00549365549569105	0.018892498347634217	10.83434155421126	-22.425343286065555	EGFR;KRAS;TP53
KEGG_2021_Human	Huntington disease	3/306	0.005297048052024124	0.018892498347634217	10.983026874115984	-22.76666252651436	COX8A;SDHB;TP53
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.018892498347634217	22.933908045977013	-30.23706529396038	EGFR;KRAS
KEGG_2021_Human	Choline metabolism in cancer	2/98	0.0061532112744065075	0.02033978171262151	20.760416666666668	-27.64199341159925	EGFR;KRAS
KEGG_2021_Human	Human papillomavirus infection	3/331	0.006599251035795172	0.021224618196206094	10.113240418118467	-20.757683091358754	EGFR;KRAS;TP53
KEGG_2021_Human	Thyroid hormone signaling pathway	2/121	0.009256905435456077	0.025617947600448214	16.699579831932773	-22.566638560549244	KRAS;TP53
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.025617947600448214	9.018735362997658	-18.187178129854335	COX8A;KRAS;SDHB
KEGG_2021_Human	Amyotrophic lateral sclerosis	3/364	0.008593668138311259	0.025617947600448214	9.149584487534627	-18.496977153394543	COX8A;SDHB;TP53
KEGG_2021_Human	AMPK signaling pathway	2/120	0.009109920890125906	0.025617947600448214	16.843220338983052	-22.75171510512794	PRKAA2;STK11
KEGG_2021_Human	Sphingolipid signaling pathway	2/119	0.008964014539605185	0.025617947600448214	16.98931623931624	-22.939511285821055	KRAS;TP53
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.025617947600448214	16.98931623931624	-22.939511285821055	KRAS;TP53
KEGG_2021_Human	Relaxin signaling pathway	2/129	0.010471317399144716	0.02832015387495957	15.631889763779528	-21.1770620526928	EGFR;KRAS
KEGG_2021_Human	Insulin signaling pathway	2/137	0.011753397776716717	0.029138631988110196	14.690740740740742	-19.931093924152265	KRAS;PRKAA2
KEGG_2021_Human	Estrogen signaling pathway	2/137	0.011753397776716717	0.029138631988110196	14.690740740740742	-19.931093924152265	EGFR;KRAS
KEGG_2021_Human	Oxidative phosphorylation	2/133	0.011103972768351109	0.029138631988110196	15.146946564885496	-20.537590301958808	COX8A;SDHB
KEGG_2021_Human	Apelin signaling pathway	2/137	0.011753397776716717	0.029138631988110196	14.690740740740742	-19.931093924152265	KRAS;PRKAA2
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.02934771465606128	14.472627737226277	-19.639406588988233	PRKAA2;TP53
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.02996072111830406	14.157142857142857	-19.21549786230027	KRAS;TP53
KEGG_2021_Human	Phospholipase D signaling pathway	2/148	0.0136245920729854	0.03179071483696594	13.565068493150685	-18.413416454449223	EGFR;KRAS
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.03447040814581419	12.847402597402597	-17.429441058365175	KRAS;TP53
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.036335820077746245	12.35625	-16.748364182562245	KRAS;TP53
KEGG_2021_Human	Tight junction	2/169	0.01753509480713479	0.03845250532475246	11.827844311377245	-16.008452091357693	PRKAA2;STK11
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.03845250532475246	6.897094430992736	-13.07371705691191	COX8A;KRAS;SDHB
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.04786683615383699	10.31020942408377	-13.840129933766221	KRAS;TP53
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.04994436772073536	9.784825870646767	-13.073912909097736	KRAS;TP53
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.04994436772073536	6.12012987012987	-11.164029011261546	EGFR;KRAS;TP53
KEGG_2021_Human	Diabetic cardiomyopathy	2/203	0.024762333575826773	0.04994436772073536	9.784825870646767	-13.073912909097736	COX8A;SDHB
KEGG_2021_Human	Rap1 signaling pathway	2/210	0.026381440852868025	0.05232319102485492	9.447115384615385	-12.577019344618241	EGFR;KRAS
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.05377317288505494	9.219483568075118	-12.240131856521	KRAS;TP53
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.0538832772969296	9.044930875576037	-11.980722307867735	KRAS;TP53
KEGG_2021_Human	Regulation of actin cytoskeleton	2/218	0.028284632569666294	0.0538832772969296	9.087962962962964	-12.04476113223121	EGFR;KRAS
KEGG_2021_Human	Ras signaling pathway	2/232	0.03174764714886429	0.05903078141741955	8.519565217391305	-11.194266119915625	EGFR;KRAS
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.061405688970866734	8.26054852320675	-10.803362590978235	EGFR;KRAS
KEGG_2021_Human	Shigellosis	2/246	0.035374463538784595	0.0637812297138692	8.01639344262295	-10.432967830507518	EGFR;TP53
KEGG_2021_Human	Citrate cycle (TCA cycle)	1/30	0.03654338399736008	0.06490541336844552	30.800766283524904	-16.574318247175444	SDHB
KEGG_2021_Human	Circadian rhythm	1/31	0.03774052193970927	0.06604591339449123	29.77037037037037	-16.126223630092912	PRKAA2
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.07383448109904223	7.192804428044281	-9.169844698845731	COX8A;SDHB
KEGG_2021_Human	Aldosterone-regulated sodium reabsorption	1/37	0.04489527895199197	0.07632197421838634	24.790123456790123	-13.876145105511855	KRAS
KEGG_2021_Human	Ferroptosis	1/41	0.04963848036556211	0.0831968896267872	22.3	-12.692261742471414	TP53
KEGG_2021_Human	Ovarian steroidogenesis	1/51	0.0614038724928517	0.10148695592568546	17.817777777777778	-10.44262436810124	CYP19A1
KEGG_2021_Human	VEGF signaling pathway	1/59	0.07072162222736704	0.11528593212406407	15.344827586206897	-9.124402207995153	KRAS
KEGG_2021_Human	Long-term depression	1/60	0.07188046794101291	0.11559156331054779	15.08286252354049	-8.981081638876871	KRAS
KEGG_2021_Human	Steroid hormone biosynthesis	1/61	0.073038012879974	0.1158869804362254	14.829629629629629	-8.841826114974799	CYP19A1
KEGG_2021_Human	Basal cell carcinoma	1/63	0.0753492056247738	0.11798099301773794	14.347670250896057	-8.574814690072902	TP53
KEGG_2021_Human	GnRH secretion	1/64	0.07650285602324569	0.1182316865813797	14.11816578483245	-8.446736055993485	KRAS
KEGG_2021_Human	Long-term potentiation	1/67	0.07995603885498047	0.11957004766256919	13.47138047138047	-8.082458738692866	KRAS
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.11957004766256919	12.880837359098228	-7.74542097629872	EGFR
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.11957004766256919	12.880837359098228	-7.74542097629872	KRAS
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.11957004766256919	13.47138047138047	-8.082458738692866	KRAS
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.11957004766256919	13.071895424836601	-7.854937277937848	KRAS
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.11957004766256919	13.26865671641791	-7.96724592924887	KRAS
KEGG_2021_Human	Adherens junction	1/71	0.08454220466511847	0.11976812327558449	12.695238095238095	-7.638591016595616	EGFR
KEGG_2021_Human	p53 signaling pathway	1/73	0.0868275630671275	0.12155858829397849	12.339506172839506	-7.43259286356604	TP53
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.09591773965141367	0.13272338393625846	11.094444444444445	-6.698191160265787	KRAS
KEGG_2021_Human	Cardiac muscle contraction	1/87	0.10268183855515577	0.1404498711271671	10.31266149870801	-6.225752347944314	COX8A
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.1434041659533119	9.961298377028713	-6.010407578745034	PRKAA2
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.14478390053056922	9.739926739926739	-5.8737398650795125	TP53
KEGG_2021_Human	Melanogenesis	1/101	0.11828795027183354	0.15300289219943686	8.853333333333333	-5.318405524022337	KRAS
KEGG_2021_Human	Progesterone-mediated oocyte maturation	1/100	0.11718138394436346	0.15300289219943686	8.94388327721661	-5.375723879218761	KRAS
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.15300289219943686	8.94388327721661	-5.375723879218761	KRAS
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.15394063239334646	8.592233009708737	-5.152341092635986	KRAS
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.15394063239334646	8.592233009708737	-5.152341092635986	KRAS
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.15433042095590468	8.2668743509865	-4.943743954376122	PRKAA2
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.15433042095590468	8.189300411522634	-4.893732148578802	EGFR
KEGG_2021_Human	Glucagon signaling pathway	1/107	0.1249011740201087	0.15433042095590468	8.345911949685535	-4.994589105830365	PRKAA2
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.12380207979004104	0.15433042095590468	8.426455026455027	-5.046288872333345	EGFR
KEGG_2021_Human	Cholinergic synapse	1/113	0.1314697223892576	0.15644896964321656	7.892857142857143	-4.701617375992292	KRAS
KEGG_2021_Human	Serotonergic synapse	1/113	0.1314697223892576	0.15644896964321656	7.892857142857143	-4.701617375992292	KRAS
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.16258682968476437	7.4858757062146895	-4.435243302362896	KRAS
KEGG_2021_Human	Cell cycle	1/124	0.14339691916847833	0.16729640569655807	7.177055103884372	-4.231046804704064	TP53
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.17435232186273925	6.7846153846153845	-3.968927686510734	KRAS
KEGG_2021_Human	Measles	1/139	0.15942370386618251	0.18241750730842038	6.384863123993559	-3.698840756963446	TP53
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.18547190480992196	6.2018779342723	-3.57415842622014	KRAS
KEGG_2021_Human	Cushing syndrome	1/155	0.17622102470306392	0.1978330371666472	5.70995670995671	-3.235678410841787	EGFR
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.20405094468922177	5.456866804692892	-3.0596637281364782	EGFR
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.20670002153312067	5.321885521885521	-2.9652743858654524	TP53
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.22258745852340267	4.841620626151013	-2.6265948500338347	KRAS
KEGG_2021_Human	Alcoholism	1/186	0.20790875456503763	0.22491947084763161	4.734534534534535	-2.5504914662503393	KRAS
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.2272831873296531	4.5823152995927865	-2.441961042053517	KRAS
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.2272831873296531	4.5823152995927865	-2.441961042053517	TP53
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.23364778660343183	4.3488114980652295	-2.274707784911856	TP53
KEGG_2021_Human	Focal adhesion	1/201	0.22284403856827387	0.23364778660343183	4.371111111111111	-2.2907190203417165	EGFR
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.2417614088340301	4.137440758293839	-2.12256354972075	KRAS
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.25945071937306036	3.7696007696007694	-1.8563524399324505	EGFR
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.26494989820808695	3.6397024639702464	-1.7619943041292825	EGFR
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.27405044812719537	3.4603806994245243	-1.6315316807371463	EGFR
KEGG_2021_Human	Herpes simplex virus 1 infection	1/498	0.4709527127104428	0.4709527127104428	1.6926000447127207	-0.379898711570649	TP53
